Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

403 ARTÍCULOS , VIENDO DEL 376 AL 390

Prodromal posterior cortical atrophy: clinical, neuropsychological, and radiological correlation

Chan LT, Lynch W, De May M, Horton JC, Miller BL, Rabinovici GD.

Neurocase. 2015 Feb;21(1):44-55. doi: 10.1080/13554794.2013.860176. Epub 2013 Dec 5.

Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations

García-Alberca JM.

Neurologia. 2015 Jan-Feb;30(1):8-15. doi: 10.1016/j.nrl.2012.10.002. Epub 2012 Dec 15.

Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis

Viola KL, Klein WL.

Acta Neuropathol. 2015 Feb;129(2):183-206. doi: 10.1007/s00401-015-1386-3. Epub 2015 Jan 22.

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17

Kasuga K, Kikuchi M, Tokutake T, Nakaya A, Tezuka T, Tsukie T, Hara N, Miyashita A, Kuwano R, Ikeuchi T.

J Hum Genet. 2015 May;60(5):281-3. doi: 10.1038/jhg.2015.15. Epub 2015 Feb 19.

From Neurodegeneration to Brain Health: An Integrated Approach

Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz WK, Wang Y, Whitehouse P, Lerner A.

J Alzheimers Dis. 2015;46(1):271-83. doi: 10.3233/JAD-150043.

[Differential diagnosis of dementia with lewy bodies]

Orimo S.

Brain Nerve. 2015 Apr;67(4):413-25. doi: 10.11477/mf.1416200157.

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

Wang ZY, Han ZM, Liu QF, Tang W, Ye K, Yao YY.

Int Psychogeriatr. 2015 Sep;27(9):1429-38. doi: 10.1017/S1041610215000447. Epub 2015 Apr 8.

PET imaging in neurology: Alzheimer's and Parkinson's diseases

Sarikaya I.

Nucl Med Commun. 2015 Aug;36(8):775-81. doi: 10.1097/MNM.0000000000000320.

Neuroimaging signature of neuropsychiatric disorders

Worbe Y.

Curr Opin Neurol. 2015 Aug;28(4):358-64. doi: 10.1097/WCO.0000000000000220.

Can clock drawing differentiate Alzheimer's disease from other dementias?

Tan LP, Herrmann N, Mainland BJ, Shulman K.

Int Psychogeriatr. 2015 Oct;27(10):1649-60. doi: 10.1017/S1041610215000939. Epub 2015 Jul 3.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease

Cummings J, Zhong K.

Clin Pharmacol Ther. 2015 Nov;98(5):483-5. doi: 10.1002/cpt.190. Epub 2015 Aug 31.

The Concept of Subconsciousness in Alzheimer's and Parkinson's Diseases

Agid Y.

J Parkinsons Dis. 2015;5(3):643-5. doi: 10.3233/JPD-150573.

Semantic profiles in mild cognitive impairment associated with Alzheimer's and Parkinson's diseases

Guidi M, Paciaroni L, Paolini S, Scarpino O, Burn DJ.

Funct Neurol. 2015 Apr-Jun;30(2):113-8. doi: 10.11138/fneur/2015.30.2.113.

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease

Goldman JG, Aggarwal NT, Schroeder CD.

Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias